Structure Therapeutics Inc.’s shares rose after more data on the company’s experimental weight-loss pill showed it’s shaping ...

GLP-1 drugs like (Ozempic and Wegovy) have finally started to make weight loss a sustainable reality for many people with ...

“The consistent weight loss observed across multiple studies to date reaffirms aleniglipron’s potential to be a best-in-class oral GLP-1, with injectable-like efficacy that could become a backbone ...

Structure Therapeutics’ oral obesity drug elicited a placebo-adjusted weight loss of 16.3% at 44 weeks in a Phase 2 trial.

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

A slow NHS rollout has so far limited wide-ranging eligibility, meaning many patients have turned to private healthcare.

There are also other reasons to invest in Eli Lilly.

Find out more about Serena Williams' weight loss and the backlash surrounding her husband's weight loss drug company on ...